Atrial fibrillation (afib) causes stroke by allowing blood to pool and form clots inside the heart, which can then travel to the brain and block an artery. Having afib increases your stroke risk roughly fivefold compared to someone without it. The connection comes down to three overlapping problems: blood that moves too slowly, heart tissue that becomes damaged over time, and blood chemistry that shifts toward clotting.
Why Blood Pools During Afib
In a normal heartbeat, the upper chambers (atria) contract in a coordinated squeeze that pushes blood down into the lower chambers. During afib, the atria quiver chaotically instead of contracting fully. This means blood isn’t being pushed out efficiently, and some of it sits nearly still inside the chamber. That stagnant blood is visible on heart ultrasounds as a swirling, smoke-like pattern called spontaneous echocontrast, essentially a real-time sign that blood is moving too slowly and starting to thicken.
Slow-moving blood is dangerous because the clotting system interprets stagnation as a signal to form a clot. Platelets activate, clotting proteins ramp up, and inflammatory markers rise. All of these shifts in blood chemistry make clot formation far more likely than in someone whose atria are pumping normally.
Where Clots Form in the Heart
Nearly all afib-related clots originate in a small, finger-shaped pouch called the left atrial appendage (LAA). This structure branches off the main left atrium and has a narrow, irregular shape that makes it especially prone to trapping stagnant blood. In one large imaging study of patients with afib who had confirmed clots, 100% of the clots were found inside the LAA.
The LAA is essentially a dead-end pocket. Even in a healthy heart, blood flow through it is relatively slow. During afib, flow drops further, creating ideal conditions for a clot to build up along the walls. Once a clot grows large enough, or once a piece breaks off, it can escape into the left atrium, pass into the main bloodstream, and travel to the brain within seconds.
How Structural Damage Makes It Worse
Afib doesn’t just change how the heart beats. Over time, it physically remodels the atrial walls. The atrium gradually stretches and dilates, and the inner lining (endocardium) becomes damaged. Scar tissue, or fibrosis, infiltrates the muscle. This creates a vicious cycle: the more fibrosis develops, the harder it is for the atrium to contract properly, which worsens the stagnation that caused the damage in the first place.
Research from the American Heart Association shows that fibrotic regions of the atrial wall have distinctly different blood flow patterns. Blood moves more slowly along scarred tissue and tends to oscillate back and forth rather than flowing in one direction. These conditions are prothrombotic, meaning they actively encourage clot formation right at the wall surface. Patients with a higher burden of atrial fibrosis have more of these clot-prone zones, not just in the appendage but across broader areas of the atrium. This helps explain why some people with afib face higher stroke risk than others, even when their heart rhythms look similar on a monitor.
Why Afib Strokes Are More Severe
Not all strokes are equal, and strokes caused by afib tend to be among the worst. Clots that form in the heart are often larger than clots that form in narrowed arteries elsewhere in the body. A bigger clot blocks a bigger artery, cutting off blood supply to a larger area of the brain. The result is that afib-related strokes are associated with worse disability and higher mortality compared to strokes from other causes.
This is one reason that preventing a first stroke in someone with afib is so critical. The damage from an afib-related stroke is often severe enough to permanently affect mobility, speech, or cognition.
Afib You Don’t Know About Can Still Cause a Stroke
Some people have afib episodes that come and go without obvious symptoms. They may never feel palpitations or shortness of breath. When these individuals have a stroke and no clear cause is found, it’s classified as a cryptogenic stroke, meaning the origin is unknown. Extended heart monitoring after these events often reveals hidden afib episodes.
A meta-analysis published in Frontiers in Neurology estimated that about 15% of cryptogenic stroke patients are found to have occult afib when monitored long enough. Of those cases, roughly 41% appear to be directly caused by the afib rather than coincidental. That works out to about 6% of all unexplained strokes being attributable to afib that was never previously detected. This is why doctors often recommend prolonged heart monitoring after an unexplained stroke, sometimes using implantable devices that record heart rhythm continuously for months.
How Doctors Estimate Your Stroke Risk
Not everyone with afib faces the same level of danger. Doctors use a scoring tool called CHA₂DS₂-VASc to estimate your yearly stroke risk based on factors you may already know about:
- Heart failure: 1 point
- High blood pressure: 1 point
- Age 75 or older: 2 points
- Diabetes: 1 point
- Previous stroke or mini-stroke: 2 points
- Vascular disease (prior heart attack or peripheral artery disease): 1 point
- Age 65 to 74: 1 point
- Female sex: 1 point
Scores range from 0 to 9. Current guidelines from the American College of Cardiology and American Heart Association recommend blood thinners for patients whose yearly stroke risk reaches about 2%, which generally corresponds to a score of 2 or higher in men and 3 or higher in women. For people right at the borderline (a score of 1 in men, 2 in women), the decision is less clear-cut and depends on which specific risk factor is driving the score, since each factor carries a slightly different real-world risk.
How Blood Thinners and Procedures Reduce Risk
The primary way to prevent afib-related stroke is with anticoagulant medications, commonly called blood thinners. These drugs don’t dissolve existing clots, but they interrupt the clotting cascade so new clots are far less likely to form. Newer oral anticoagulants have largely replaced warfarin for most patients. Studies comparing them show stroke rates that are generally 10% to 30% lower with the newer drugs, along with a lower risk of dangerous bleeding.
For people who can’t tolerate blood thinners, there’s also a procedural option: closing off the left atrial appendage entirely. Since that’s where virtually all afib clots form, sealing it shut removes the main source of danger. This can be done surgically during open-heart procedures or with a catheter-based device. Data from a large trial found that surgical closure of the appendage reduced the risk of stroke or systemic embolism by 32%, with the rate dropping from 7.0% to 4.8% over about four years. That translates to treating 45 patients to prevent one stroke, a meaningful benefit for people at elevated risk.
The combination of understanding where clots form, who is most at risk, and how to intervene has made afib-related stroke one of the most preventable types of stroke. The key variable is whether afib is detected and treated before a stroke happens, which is why rhythm monitoring matters so much, especially after age 65.